Organisation paid for research Program year 2025 Source: CMS Open Payments

Pinehurst Medcl CLNC Endocrinology

Neither a doctor nor a teaching hospital

Research payments

$941,336

93 payments

Through program year 2025, Pinehurst Medcl CLNC Endocrinology is reported as receiving $941,336 in research payments, across 93 payments.

By program year

3 rows
Year Kind Amount Payments
2025 Research $315,525 37
2024 Research $483,557 38
2023 Research $142,254 18

Breakdown

Who paid Research payments · program years 2023–2025
  1. Janssen Research & Development, LLC $941,336 93 payments
Studies the money was for Research payments · program years 2023–2025
  1. 70033093Afl3002 $605,036 41 payments
  2. A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants with Atrial Fibrillation $302,938 25 payments
  3. 70033093Acs3003 $20,775 15 payments
  4. A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome (LIBREXIA-ACS) $12,587 12 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record